Crossmark

Value of increased soluble suppressor tumorigenicity biomarker 2 (sST2) on admission as an indicator of severity in patients with COVID-19

Crossref DOI link: https://doi.org/10.1016/j.medcle.2023.04.026

Published Print: 2023-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Arnaldos-Carrillo, María

Noguera-Velasco, José Antonio

Martínez-Ardil, Isabel M.

Riquelme-Pérez, Alejandro

Cebreiros-López, Iria

Hernández-Vicente, Álvaro

Ros-Lucas, José Antonio

Khan, Amjad

Bayes-Genís, Antoni

Pascual-Figal, Domingo
License Information

Text and Data Mining valid from 2023-09-01

stm-asf valid from 2023-09-01

stm-asf valid from 2023-09-01

stm-asf valid from 2023-09-01

stm-asf valid from 2023-09-01

stm-asf valid from 2023-09-01
More Information

This article is maintained by: Elsevier

Article Title: Value of increased soluble suppressor tumorigenicity biomarker 2 (sST2) on admission as an indicator of severity in patients with COVID-19

Journal Title: Medicina Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcle.2023.04.026

Content Type: article

Copyright: © 2023 Elsevier España, S.L.U. All rights reserved.